Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
Unity Bancorp
UNTY
$591M
| $181K | ﹤0.01% |
7,998
+3,954
| +98% | +$87.5K |
|
|
PTR
5027
CALL
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $181K | ﹤0.01% |
3,600
-28,000
| -89% | -$1.38M |
|
5028
Princeton Bancorp
BPRN
$281M
| $180K | ﹤0.01% |
5,723
+2,849
| +99% | +$83.8K |
|
5029
Quad
QUAD
$536M
| $180K | ﹤0.01% |
38,505
+16,426
| +74% | +$103K |
|
5030
Wave Life Sciences
WVE
$1.09B
| $180K | ﹤0.01% |
22,563
-896
| -4% | -$22K |
|
|
HARP
5031
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $180K | ﹤0.01% |
1,222
+569
| +87% | +$86.3K |
|
5032
CALL
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.07B
| $179K | ﹤0.01% |
1,633
-1,300
| -44% | -$141K |
|
|
PTN
5033
Palatin Technologies
PTN
$13.7M
| $179K | ﹤0.01% |
183
+103
| +129% | +$104K |
|
5034
OptimizeRx
OPRX
$114M
| $178K | ﹤0.01% |
17,294
+6,891
| +66% | +$78.1K |
|
5035
Riverview Bancorp
RVSB
$107M
| $178K | ﹤0.01% |
21,667
+10,753
| +99% | +$80.5K |
|
5036
SK Telecom
SKM
$12.1B
| $178K | ﹤0.01% |
4,675
-15,449
| -77% | -$578K |
|
|
SWN
5037
PUT
DELISTED
Southwestern Energy Company
SWN
| $178K | ﹤0.01% |
73,500
+6,200
| +9% | +$12.8K |
|
5038
PUT
iShares Russell 1000 Value ETF
IWD
$82.2B
| $177K | ﹤0.01% |
1,300
+800
| +160% | +$105K |
|
5039
Zymeworks
ZYME
$1.61B
| $177K | ﹤0.01% |
3,900
| – | – |
|
|
NAGE
5040
Niagen Bioscience
NAGE
$271M
| $177K | ﹤0.01% |
41,011
+21,519
| +110% | +$76.5K |
|
|
TCFC
5041
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $177K | ﹤0.01% |
4,987
+2,494
| +100% | +$84.5K |
|
5042
NACCO Industries
NC
$357M
| $176K | ﹤0.01% |
3,766
+1,889
| +101% | +$100K |
|
5043
CALL
Middleby
MIDD
$6.04B
| $175K | ﹤0.01% |
1,600
-200
| -11% | -$22.9K |
|
5044
Oragenics
OGEN
$2.26M
| $175K | ﹤0.01% |
186
+19
| +11% | +$16.9K |
|
|
PHX
5045
DELISTED
PHX Minerals
PHX
| $175K | ﹤0.01% |
15,633
+7,765
| +99% | +$102K |
|
5046
ProShares UltraShort QQQ
QID
$282M
| $175K | ﹤0.01% |
371
+312
| +529% | +$167K |
|
5047
Willis Lease Finance
WLFC
$1.7B
| $175K | ﹤0.01% |
8,883
+4,452
| +100% | +$86.7K |
|
|
MLVF
5048
DELISTED
Malvern Bancorp, Inc.
MLVF
| $175K | ﹤0.01% |
7,619
+3,817
| +100% | +$86.4K |
|
5049
Fidelity D&D Bancorp
FDBC
$306M
| $174K | ﹤0.01% |
2,793
+1,411
| +102% | +$91.6K |
|
5050
ALPS Strategic Income Fund
RIGS
$60.1M
| $174K | ﹤0.01% |
7,000
| – | – |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.